Digital Genome Market Size to Hit US$ 31.3 Billion by 2030| Exhibit at a CAGR of 10% during the forecast period (2022-2030)

Pune, Nov. 11, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Digital Genome Market is expected to clock US$ 31.3 billion by 2030, owing to rising awareness regarding the early detection of genetic diseases and the adoption of advanced technologies. The rapidly increasing adoption of digitalization due to growing urbanization is a major driver for the Digital Genome Market. This exclusive information is published by Growth Plus Reports in its report titled “Digital Genome Market – Global Outlook & Forecast 2022-2030

To get a first-hand overview of the report, Request a Sample at@

https://growthplusreports.com/inquiry/request-sample/digital-genome-market/7910

Market Drivers

The increasing technological advancements pertaining to the digital genome, growing adoption of personalised medicine, constantly evolving disease patterns, and rising research and development activities pertaining to the digital genome are the major factors fuelling market growth. The digital genome's increasing technological advancement is propelling market growth. For instance, July 2021, GE Healthcare and SOPHiA GENETICS, a global healthcare data-sharing network, collaborated on developing genomic-based AI to advance cancer care. The incorporation of genomics-based artificial intelligence into oncology workflow solutions would be a game changer for integrated cancer medicine and future clinical research, which is increasingly reliant on the ability to identify patients who are most likely to respond to new therapies.

Excerpts from ‘By Product Type Segmentation’

Based on product type, the digital genome has been segmented into

• Sequence & Analysers Instruments
• Dna/Rna Analysis Kits
• Sequencing & Analysis Software
• Sample Preparation Instrument

The sequencing and analysis instrument is expected to command a sizable market share. Sequence analysis is the process of subjecting a DNA, RNA, or peptide sequence to any of a variety of analytical methods in order to better understand its features, function, structure, or evolution. Methodologies used include sequence alignment and searches against biological databases, among others. Several market participants are also contributing to market growth. For instance, with the launch of the TruSight Software Suite in July 2020, Illumina, Inc. introduced turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing. Additionally, in May 2022, customers using Illumina NextSeq 1000 and NextSeq 2000 sequencing systems and the GeoMx Digital Spatial Profiler will benefit from a seamless, cloud-based workflow, according to NanoString Technologies, Inc. As a result of the aforementioned developments, the market is expected to grow significantly over the forecast period.

Excerpts from ‘By Region Segmentation’

Based on region, the global digital genome market has been segmented into

• North America
• Europe
• Asia Pacific
• Rest of the World

North America is expected to dominate the overall genomics market throughout the forecast period due to the rising incidence of chronic diseases such as cancer, increasing government entities' investment in research, raising patient awareness, and the availability of advanced healthcare infrastructure, all of which are contributing to the growing technological advances in this sector and rising demand for biotechnological procedures in the region. The current global pandemic has created numerous opportunities for domestic market participants operating in the space. For instance, in March 2021, Applied DNA Sciences Inc. launched the Linea COVID-19 Selective Genomic Surveillance Mutation Panel to improve the utility of the United States' limited Next Generation Sequencing (NGS) resources in tracking SARS-CoV-2 Variants of Concern (VOCs) at the local, state, and federal levels.

Excerpts from ‘Competitive Landscape’

Some of the prominent players in the global digital genome market include

• Biomérieux
• Genmark Diagnostics, Inc.
• Illumina, Inc.
• Thermo Fisher Scientific
• Nanostring Technologies, Inc.
• Inscripta Inc.
• GE Healthcare Genomic Health, Inc.
• Pacific Bioscience
• Perkinelmer Inc.
• Qiagen Quest Diagnostics
• Agilent Technologies Inc.
• Becton
• Dickinson And Company
• F. Hoffmann-La Roche Ltd.
• Regeneron Pharmaceuticals, Inc.

The digital genome market is competitive, with several global and international market players present. Partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions are some of the growth strategies used by the key players to increase their market presence.

Make an inquiry before buying:

https://growthplusreports.com/inquiry/before-buying/digital-genome-market/7910

Table of Content

1. INTRODUCTION
   1. Market Ecosystem 
   2. Timeline Under Consideration
      1. Historical Years - 2020
      2. Base Years - 2021
      3. Forecasted Years – 2022 to 2030 
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions       
3. PREMIUM INSIGHTS
   1. Current Market Trend (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2021) 
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL DIGITAL GENOME MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
   1. Sequence & Analysers Instruments
   2. DNA/RNA Analysis kits
   3. Sequencing & Analysis Software 
   4. Sample Preparation Instrument
6. GLOBAL DIGITAL GENOME MARKET - ANALYSIS & FORECAST, BY APPLICATION
   1. Microbiology, Reproductive & Genetic
   2. Transplant & Agriculture
   3. Forensics 
   4. Research & Development
7. GLOBAL DIGITAL GENOME MARKET - ANALYSIS & FORECAST, BY END USER
   1. Academic Research Institutes
   2. Diagnostics & Forensic Labs
   3. Hospitals 
   4. Bio-pharmaceuticals Companies

TOC Continue…

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pipeline Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Click on the following link to buy the Digital Genome Market:

https://growthplusreports.com/checkout?_token=7eLKUBBwancfSMrYjc5guAbj8X08KJtqzmraSHdP&report_id=7910&license=Single

About Us        

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

 Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

            Manan Sethi
Director, Market Insights
Email: enquire@growthplusreports.com
Phone no: +91 96545 76783
Web: https://growthplusreports.com/